Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy (Q44801683)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 December 2011

Language	Label	Description	Also known as
English	Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy	scientific article published on 21 December 2011

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy (English)

1 reference

Europe PubMed Central

6 December 2017

0 references

author name string

Mariko Horiike

1

1 reference

Europe PubMed Central

6 December 2017

Shingo Iwami

2

1 reference

Europe PubMed Central

6 December 2017

Makoto Kodama

3

1 reference

Europe PubMed Central

6 December 2017

Akihiko Sato

4

1 reference

Europe PubMed Central

6 December 2017

Yuji Watanabe

5

1 reference

Europe PubMed Central

6 December 2017

Mika Yasui

6

1 reference

Europe PubMed Central

6 December 2017

Yuki Ishida

7

1 reference

Europe PubMed Central

6 December 2017

Takeshi Kobayashi

8

1 reference

Europe PubMed Central

6 December 2017

Tomoyuki Miura

9

1 reference

Europe PubMed Central

6 December 2017

Tatsuhiko Igarashi

10

1 reference

Europe PubMed Central

6 December 2017

language of work or name

0 references

publication date

21 December 2011

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

423

1 reference

Europe PubMed Central

6 December 2017

2

1 reference

Europe PubMed Central

6 December 2017

107-118

1 reference

Europe PubMed Central

6 December 2017

Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Follicular dendritic cell contributions to HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Re-emergence of HIV after stopping therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

T cell dynamics in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

CLINICAL CALORIMETRY

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Bootstrap Methods: Another Look at the Jackknife

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Dose translation from animal to human studies revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2011.11.024

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44801683&oldid=2043388713"